Quarter Financials
Kindred Biosciences, Inc. (KIN)
$9.25
+0.01 (+-%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
|---|
| Net Income | -9 | -10 | -11 | -12 | 24 | -23 | -16 | -15 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -264 | -255 | -245 | -234 | -222 | -246 | -223 | -207 |
|---|
|
Year
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
|---|
| Capital Expenditure | -0 | -0 | -1 | -0 | -1 | -1 | -1 | -1 |
|---|
| Net PPE | 30 | 31 | 32 | 32 | 33 | 33 | 33 | 31 |
|---|
|
Year
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
2020 Q1
|
2019 Q4
|
2019 Q3
|
|---|
| New Purchases | -40 | -36 | -17 | -35 | -18 | -6 | -18 | -13 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|